Oxis Biotech Executes Option Agreement to Certain Patents/Intellectual Properties Owned by University of Pittsburgh
Oxis Biotech, Inc. has announced the execution of an exclusive option agreement with the University of Pittsburgh related to certain patents/intellectual properties developed by Dr. Xiang-Qun Xie, Associate Dean for Research Innovation and Professor, Pharmaceutical Sciences, School of Pharmacy. These patents/intellectual properties relate to novel compositions-of-matter which could prove useful as therapeutics for the treatment of various human diseases.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063